Marc Yune, MD
Plastic and Reconstructive Surgery · Roswell, GANPI 1215975974
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $40,348 of the $64,301 with a category attached, or 62.7%. AbbVie accounts for 92.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $19,559 and has fallen 54.6% since, to $8,878 in 2025. Among plastic and reconstructive surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 470 payments — averaging $136.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$60K
- Merz North America, Inc.$4K
- Novo Nordisk$123
- Sanofi$97
- Galderma Laboratories, L.p.$62
- Sun Pharmaceutical Industries Inc.$39
- plus $68 from 3 others
What the payments were for
- Consulting fees$12,13519%
- Speaking & faculty fees$40,34863%
- Travel & lodging$5841%
- Food & beverage$11,23517%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 430 | $59,736 |
| Merz North America, Inc. | 26 | $4,176 |
| Novo Nordisk | 1 | $123 |
| Sanofi | 3 | $97 |
| Galderma Laboratories, L.p. | 4 | $62 |
| Sun Pharmaceutical Industries Inc. | 2 | $39 |
| EPI Health, LLC | 2 | $35 |
| Lilly USA, LLC | 1 | $19 |
| Apyx Medical Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KYBELLA$4,785
- BOTOX COSMETIC$872
- BOTOX$148
- Wegovy$123
How this compares
$64,301 in reported general payments places this provider in the 90th percentile of 83 plastic and reconstructive surgery providers in Georgia.
See all plastic and reconstructive surgery providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 15 | $182 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $137 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $85 |
| Cephalexin | 11 | $33 |
| Alprazolam | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Roswell
- Rajiv SoodAugusta$502K
- Carmen KavaliAtlanta$233K
- Randal RuddermanAlpharetta$207K
- James NamnoumAtlanta$97K
- Michael MirzabeigiAtlanta$71K
- Katherine SantosaAtlanta$65K
- Asaf YalifAlpharetta$43K
- Luther BakerColquitt$40K
- Olumayowa AbiodunAlbany$35K
- Seth YellinMarietta$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.